Skip to content
Safety ProfileEvidence-Based

Atosiban Side Effects

Honest, evidence-based safety analysis for Atosiban. Frequency data, severity classification, data limitations, and what we genuinely don't know.

Quick Answer

Atosiban is generally well-tolerated, with nausea, headache, and injection site reactions being the most common side effects. Serious adverse effects are rare. It has a more favorable cardiovascular safety profile than beta-agonists, but potential risks should still be discussed with a healthcare provider.

→ Atosiban Dosage→ Atosiban Benefits→ Full Atosiban Profile
Table of Contents

Data Context: What We Actually Know

Important: data limitations

While atosiban has been in clinical use for over two decades, long-term safety data is still being collected. Reported side effects are primarily based on clinical trial data and post-marketing surveillance.

Side Effects by Severity

MildModerateSevere / Serious
NauseaMild

Frequency: Common (10-12%)

Usually mild and transient. May resolve on its own.

HeadacheMild

Frequency: Common (5-10%)

Typically mild and self-limiting.

Injection site reactionsMild

Frequency: Common

Local pain, redness, and swelling at the IV infusion site. Rotate injection sites if possible.

Dizziness and hot flashesMild

Frequency: Uncommon (3-5%)

Mild vasomotor symptoms that usually resolve quickly.

Hyperglycemia in neonatesMild

Frequency: Rare (signal from one trial, not confirmed in meta-analyses)

Monitor neonates for hyperglycemia.

Contraindications

  • ✕Gestation < 24 weeks or > 33 weeks
  • ✕Premature rupture of membranes
  • ✕Intrauterine fetal death
  • ✕Suspected intrauterine infection
  • ✕Antepartum hemorrhage requiring immediate delivery
  • ✕Fetal distress
  • ✕Known hypersensitivity to atosiban

Drug Interactions

No formal pharmacokinetic drug interaction studies have been conducted for most research peptides. The interactions below are theoretical, mechanism-based, or derived from limited case reports.
  • ⚠No significant drug interactions have been reported.

Frequently Asked Questions

What are the most common side effects of atosiban?
The most common side effects are nausea, headache, and injection site reactions. These are usually mild and transient.
Is atosiban safe for the baby?
Atosiban has minimal fetal exposure and no direct fetal cardiovascular or metabolic effects. It is considered safe for the baby when used appropriately under medical supervision.
Are there any serious side effects associated with atosiban?
Serious side effects are rare. One trial showed a possible increase in neonatal hyperglycemia, but subsequent meta-analyses have not confirmed this. Monitor neonates closely.
Who should not take atosiban?
Atosiban is contraindicated in women with gestation less than 24 weeks or greater than 33 weeks, premature rupture of membranes, intrauterine fetal death, suspected intrauterine infection, antepartum hemorrhage requiring immediate delivery, fetal distress, or known hypersensitivity to atosiban.
Does atosiban interact with other medications?
No significant drug interactions have been reported with atosiban. However, it is always important to inform your healthcare provider of all medications you are taking.

References

  1. 1
    Atosiban for threatened preterm labor.(1999)PubMed ↗
  2. 2
    Effectiveness and safety of atosiban versus beta-adrenergic agonists in the treatment of preterm labour: systematic review(2004)PubMed ↗
  3. 3
    Atosiban: a review of its use in the treatment of preterm labour.(2007)PubMed ↗

Last updated: 2026-02-19